| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Viral | 39 | 2025 | 348 | 6.490 |
Why?
|
| Antibodies, Neutralizing | 29 | 2025 | 163 | 6.050 |
Why?
|
| Influenza, Human | 20 | 2025 | 370 | 5.720 |
Why?
|
| Influenza Vaccines | 17 | 2025 | 173 | 5.500 |
Why?
|
| HIV-1 | 16 | 2024 | 182 | 4.830 |
Why?
|
| HIV Antibodies | 15 | 2024 | 39 | 4.500 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 15 | 2020 | 41 | 4.230 |
Why?
|
| Nanoparticles | 15 | 2024 | 197 | 3.710 |
Why?
|
| HIV Infections | 19 | 2024 | 974 | 2.970 |
Why?
|
| Peptides | 14 | 2025 | 672 | 2.940 |
Why?
|
| Orthomyxoviridae | 6 | 2024 | 48 | 2.730 |
Why?
|
| Orthomyxoviridae Infections | 8 | 2022 | 57 | 2.480 |
Why?
|
| Polyethylene Glycols | 11 | 2024 | 377 | 2.370 |
Why?
|
| Phagocytosis | 8 | 2024 | 116 | 2.210 |
Why?
|
| Crystallography, X-Ray | 15 | 2018 | 527 | 1.890 |
Why?
|
| Proteins | 7 | 2023 | 816 | 1.740 |
Why?
|
| Antibody Formation | 8 | 2025 | 181 | 1.600 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2019 | 22 | 1.580 |
Why?
|
| Simian Immunodeficiency Virus | 3 | 2018 | 20 | 1.570 |
Why?
|
| Receptors, Fc | 6 | 2022 | 40 | 1.540 |
Why?
|
| Immunoglobulin Fc Fragments | 4 | 2020 | 26 | 1.520 |
Why?
|
| Lymphocyte Activation | 10 | 2025 | 810 | 1.500 |
Why?
|
| Receptors, IgG | 11 | 2025 | 68 | 1.480 |
Why?
|
| Cnidarian Venoms | 3 | 2017 | 19 | 1.460 |
Why?
|
| Solid-Phase Synthesis Techniques | 5 | 2025 | 7 | 1.380 |
Why?
|
| Models, Molecular | 11 | 2021 | 1375 | 1.250 |
Why?
|
| CD8-Positive T-Lymphocytes | 15 | 2025 | 668 | 1.230 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 10 | 2024 | 83 | 1.210 |
Why?
|
| Killer Cells, Natural | 7 | 2023 | 294 | 1.190 |
Why?
|
| Immunogenicity, Vaccine | 4 | 2025 | 19 | 1.190 |
Why?
|
| Amino Acid Sequence | 17 | 2021 | 2092 | 1.170 |
Why?
|
| Esters | 4 | 2016 | 31 | 1.120 |
Why?
|
| Humans | 110 | 2025 | 96127 | 1.110 |
Why?
|
| Semen | 3 | 2021 | 17 | 1.020 |
Why?
|
| Animals | 49 | 2024 | 28945 | 1.000 |
Why?
|
| Insulin | 4 | 2016 | 1190 | 1.000 |
Why?
|
| Liposomes | 6 | 2024 | 101 | 0.990 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2025 | 488 | 0.950 |
Why?
|
| Sea Anemones | 2 | 2017 | 16 | 0.930 |
Why?
|
| Scorpion Venoms | 2 | 2016 | 25 | 0.920 |
Why?
|
| Green Chemistry Technology | 1 | 2025 | 4 | 0.920 |
Why?
|
| Macaca nemestrina | 5 | 2020 | 23 | 0.910 |
Why?
|
| AIDS Vaccines | 5 | 2022 | 15 | 0.910 |
Why?
|
| Sulfhydryl Compounds | 2 | 2017 | 72 | 0.890 |
Why?
|
| Chemokine CCL1 | 2 | 2014 | 4 | 0.860 |
Why?
|
| B-Lymphocytes | 11 | 2025 | 771 | 0.850 |
Why?
|
| Vaccination | 14 | 2025 | 311 | 0.850 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2025 | 432 | 0.840 |
Why?
|
| Influenza Pandemic, 1918-1919 | 1 | 2023 | 1 | 0.840 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 8 | 2021 | 151 | 0.840 |
Why?
|
| Protein Corona | 2 | 2020 | 2 | 0.840 |
Why?
|
| Serine | 2 | 2014 | 108 | 0.820 |
Why?
|
| Protein Folding | 6 | 2017 | 295 | 0.820 |
Why?
|
| Doxorubicin | 1 | 2024 | 304 | 0.810 |
Why?
|
| Hemagglutination Inhibition Tests | 7 | 2025 | 42 | 0.810 |
Why?
|
| Stereoisomerism | 9 | 2018 | 104 | 0.810 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2024 | 151 | 0.810 |
Why?
|
| Spike Glycoprotein, Coronavirus | 11 | 2025 | 59 | 0.770 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 117 | 0.770 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 7 | 2025 | 115 | 0.770 |
Why?
|
| Polymers | 6 | 2024 | 220 | 0.760 |
Why?
|
| Drug Delivery Systems | 3 | 2024 | 198 | 0.750 |
Why?
|
| HIV Protease | 2 | 2012 | 10 | 0.740 |
Why?
|
| Mucosal-Associated Invariant T Cells | 2 | 2019 | 13 | 0.740 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 38 | 0.710 |
Why?
|
| Protein Conformation | 7 | 2021 | 935 | 0.710 |
Why?
|
| Molecular Sequence Data | 11 | 2016 | 3041 | 0.690 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 380 | 0.690 |
Why?
|
| Immunity, Humoral | 4 | 2023 | 74 | 0.690 |
Why?
|
| Cytokines | 8 | 2025 | 872 | 0.690 |
Why?
|
| T-Lymphocytes | 6 | 2025 | 1316 | 0.660 |
Why?
|
| Chemistry Techniques, Synthetic | 2 | 2018 | 9 | 0.660 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2021 | 407 | 0.640 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2018 | 29 | 0.640 |
Why?
|
| Adjuvants, Immunologic | 2 | 2023 | 174 | 0.630 |
Why?
|
| Vaccines, Inactivated | 6 | 2025 | 36 | 0.630 |
Why?
|
| Virus Activation | 2 | 2017 | 43 | 0.590 |
Why?
|
| Integrins | 1 | 2019 | 80 | 0.580 |
Why?
|
| Antibodies, Bispecific | 1 | 2019 | 37 | 0.580 |
Why?
|
| Monocytes | 2 | 2019 | 231 | 0.580 |
Why?
|
| Carbon Isotopes | 2 | 2016 | 76 | 0.580 |
Why?
|
| Immunoglobulin G | 12 | 2025 | 481 | 0.560 |
Why?
|
| Male | 31 | 2025 | 45870 | 0.560 |
Why?
|
| Recombinant Proteins | 5 | 2019 | 1034 | 0.540 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 60 | 0.540 |
Why?
|
| Glycoproteins | 1 | 2018 | 233 | 0.540 |
Why?
|
| Insulin Lispro | 1 | 2017 | 3 | 0.520 |
Why?
|
| Threonine | 1 | 2017 | 34 | 0.520 |
Why?
|
| Isoleucine | 1 | 2017 | 19 | 0.520 |
Why?
|
| Adaptive Immunity | 2 | 2021 | 180 | 0.520 |
Why?
|
| Hydrofluoric Acid | 1 | 2016 | 6 | 0.520 |
Why?
|
| Influenza A virus | 4 | 2023 | 177 | 0.510 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2016 | 24 | 0.500 |
Why?
|
| Epitopes | 5 | 2021 | 258 | 0.500 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2016 | 35 | 0.500 |
Why?
|
| Immunity | 3 | 2023 | 157 | 0.500 |
Why?
|
| Immunoglobulins, Intravenous | 4 | 2023 | 70 | 0.490 |
Why?
|
| Fluorescent Dyes | 2 | 2016 | 262 | 0.490 |
Why?
|
| Macaca | 4 | 2021 | 94 | 0.490 |
Why?
|
| Oxygen Isotopes | 1 | 2016 | 17 | 0.490 |
Why?
|
| Viral Proteins | 2 | 2020 | 289 | 0.480 |
Why?
|
| Germinal Center | 3 | 2021 | 65 | 0.470 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 4 | 2019 | 8 | 0.460 |
Why?
|
| Chemistry, Analytic | 1 | 2015 | 2 | 0.460 |
Why?
|
| Peptidomimetics | 1 | 2015 | 3 | 0.450 |
Why?
|
| Erythropoietin | 2 | 2013 | 91 | 0.450 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 298 | 0.450 |
Why?
|
| Biological Science Disciplines | 1 | 2015 | 14 | 0.450 |
Why?
|
| Immunologic Memory | 6 | 2024 | 188 | 0.440 |
Why?
|
| Synthetic Biology | 1 | 2014 | 16 | 0.440 |
Why?
|
| Mucous Membrane | 1 | 2014 | 85 | 0.430 |
Why?
|
| Testis | 1 | 2015 | 153 | 0.430 |
Why?
|
| Adult | 19 | 2025 | 28718 | 0.430 |
Why?
|
| Female | 28 | 2025 | 50063 | 0.430 |
Why?
|
| Lipids | 3 | 2024 | 285 | 0.430 |
Why?
|
| Australia | 7 | 2023 | 124 | 0.420 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 377 | 0.420 |
Why?
|
| Cross Reactions | 4 | 2024 | 115 | 0.410 |
Why?
|
| Middle Aged | 20 | 2025 | 28363 | 0.410 |
Why?
|
| Mass Spectrometry | 6 | 2016 | 206 | 0.400 |
Why?
|
| Mercaptoethanol | 1 | 2013 | 7 | 0.400 |
Why?
|
| Carboxylic Acids | 1 | 2013 | 17 | 0.390 |
Why?
|
| Immunization, Passive | 3 | 2023 | 75 | 0.390 |
Why?
|
| Aspartic Acid | 1 | 2012 | 67 | 0.370 |
Why?
|
| Protein Binding | 6 | 2021 | 1561 | 0.370 |
Why?
|
| Biocatalysis | 1 | 2012 | 56 | 0.370 |
Why?
|
| Crystallography | 1 | 2012 | 46 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 416 | 0.370 |
Why?
|
| Vaccines, Synthetic | 3 | 2024 | 60 | 0.360 |
Why?
|
| Mice | 16 | 2024 | 12562 | 0.360 |
Why?
|
| Immunodominant Epitopes | 2 | 2021 | 23 | 0.350 |
Why?
|
| Aged | 12 | 2025 | 20964 | 0.350 |
Why?
|
| Epitopes, T-Lymphocyte | 5 | 2024 | 96 | 0.350 |
Why?
|
| Hemagglutinins | 3 | 2022 | 22 | 0.350 |
Why?
|
| HLA-A2 Antigen | 2 | 2021 | 32 | 0.340 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 346 | 0.340 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 334 | 0.340 |
Why?
|
| Plant Proteins | 1 | 2011 | 143 | 0.340 |
Why?
|
| Micelles | 2 | 2021 | 53 | 0.340 |
Why?
|
| Proline | 1 | 2010 | 56 | 0.340 |
Why?
|
| RNA, Messenger | 4 | 2024 | 2092 | 0.330 |
Why?
|
| Hematologic Neoplasms | 2 | 2025 | 372 | 0.330 |
Why?
|
| Protein Structure, Tertiary | 4 | 2017 | 750 | 0.320 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2017 | 311 | 0.320 |
Why?
|
| Viremia | 3 | 2019 | 53 | 0.320 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 7 | 0.320 |
Why?
|
| Proinsulin | 1 | 2010 | 124 | 0.320 |
Why?
|
| Glycopeptides | 1 | 2009 | 18 | 0.320 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2023 | 290 | 0.310 |
Why?
|
| Immunoassay | 2 | 2020 | 100 | 0.290 |
Why?
|
| Viral Vaccines | 2 | 2020 | 48 | 0.290 |
Why?
|
| Anti-Retroviral Agents | 2 | 2019 | 35 | 0.290 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2551 | 0.280 |
Why?
|
| Crystallization | 3 | 2018 | 216 | 0.280 |
Why?
|
| Antibodies, Monoclonal | 6 | 2021 | 1431 | 0.280 |
Why?
|
| Cell Line | 4 | 2016 | 2533 | 0.270 |
Why?
|
| Granulocytes | 2 | 2019 | 41 | 0.270 |
Why?
|
| Betacoronavirus | 2 | 2020 | 284 | 0.260 |
Why?
|
| Hydroxamic Acids | 2 | 2017 | 52 | 0.260 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2017 | 218 | 0.250 |
Why?
|
| Tissue Distribution | 2 | 2024 | 297 | 0.250 |
Why?
|
| Binding Sites | 4 | 2021 | 1167 | 0.240 |
Why?
|
| Disease Progression | 2 | 2024 | 1568 | 0.240 |
Why?
|
| Kv1.3 Potassium Channel | 2 | 2017 | 14 | 0.240 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2023 | 111 | 0.230 |
Why?
|
| Molecular Structure | 3 | 2020 | 310 | 0.230 |
Why?
|
| Indoles | 2 | 2017 | 317 | 0.230 |
Why?
|
| Nucleoproteins | 2 | 2022 | 23 | 0.230 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2943 | 0.230 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2017 | 66 | 0.220 |
Why?
|
| Hydrolysis | 2 | 2016 | 146 | 0.220 |
Why?
|
| Influenza B virus | 1 | 2024 | 33 | 0.220 |
Why?
|
| Polymerization | 3 | 2021 | 36 | 0.220 |
Why?
|
| Isotope Labeling | 2 | 2016 | 53 | 0.210 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2022 | 35 | 0.210 |
Why?
|
| Cohort Studies | 4 | 2024 | 3107 | 0.210 |
Why?
|
| Protein Splicing | 1 | 2023 | 2 | 0.210 |
Why?
|
| Inteins | 1 | 2023 | 3 | 0.210 |
Why?
|
| Protein Multimerization | 4 | 2021 | 196 | 0.210 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 3 | 2025 | 87 | 0.210 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 156 | 0.210 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2023 | 1 | 0.210 |
Why?
|
| Disulfides | 2 | 2017 | 65 | 0.210 |
Why?
|
| Antibodies | 2 | 2023 | 357 | 0.210 |
Why?
|
| Glycosylation | 2 | 2014 | 137 | 0.210 |
Why?
|
| Particle Size | 2 | 2021 | 126 | 0.210 |
Why?
|
| Young Adult | 7 | 2025 | 7025 | 0.200 |
Why?
|
| Immunity, Cellular | 3 | 2020 | 191 | 0.200 |
Why?
|
| Fluoxetine | 1 | 2023 | 42 | 0.200 |
Why?
|
| Phenotype | 6 | 2024 | 2579 | 0.200 |
Why?
|
| Silicon Dioxide | 2 | 2020 | 39 | 0.200 |
Why?
|
| Ferrets | 2 | 2020 | 50 | 0.200 |
Why?
|
| History, 20th Century | 1 | 2023 | 327 | 0.190 |
Why?
|
| Antigens | 2 | 2023 | 231 | 0.180 |
Why?
|
| Vaccines | 1 | 2023 | 84 | 0.180 |
Why?
|
| Pyrogallol | 1 | 2021 | 1 | 0.180 |
Why?
|
| HLA-A24 Antigen | 1 | 2021 | 21 | 0.180 |
Why?
|
| Nanocapsules | 1 | 2021 | 12 | 0.180 |
Why?
|
| Single-Domain Antibodies | 1 | 2021 | 8 | 0.180 |
Why?
|
| Blood | 1 | 2021 | 69 | 0.180 |
Why?
|
| Metal-Organic Frameworks | 1 | 2021 | 23 | 0.170 |
Why?
|
| Viral Load | 3 | 2017 | 164 | 0.170 |
Why?
|
| Neutrophils | 2 | 2019 | 334 | 0.170 |
Why?
|
| Peptide Fragments | 2 | 2020 | 477 | 0.170 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 63 | 0.170 |
Why?
|
| Antigens, Viral | 2 | 2020 | 135 | 0.170 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2020 | 2 | 0.170 |
Why?
|
| Bacteria | 2 | 2017 | 517 | 0.170 |
Why?
|
| Extinction, Biological | 1 | 2021 | 97 | 0.170 |
Why?
|
| Lung | 3 | 2024 | 1382 | 0.170 |
Why?
|
| Nanotechnology | 2 | 2018 | 73 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 4 | 2024 | 1125 | 0.170 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 155 | 0.170 |
Why?
|
| Kinetics | 3 | 2017 | 1562 | 0.170 |
Why?
|
| Neutralization Tests | 4 | 2021 | 77 | 0.170 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2020 | 7 | 0.170 |
Why?
|
| Ligands | 4 | 2020 | 478 | 0.170 |
Why?
|
| Rectum | 1 | 2021 | 151 | 0.170 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2020 | 8 | 0.160 |
Why?
|
| Retinal Vessels | 1 | 2021 | 51 | 0.160 |
Why?
|
| Communicable Diseases | 1 | 2021 | 69 | 0.160 |
Why?
|
| Healthy Volunteers | 2 | 2018 | 157 | 0.160 |
Why?
|
| Cysteine | 2 | 2013 | 146 | 0.160 |
Why?
|
| South Australia | 1 | 2020 | 6 | 0.160 |
Why?
|
| Squalene | 1 | 2020 | 2 | 0.160 |
Why?
|
| Blood Proteins | 1 | 2020 | 151 | 0.160 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 2017 | 45 | 0.160 |
Why?
|
| Polysorbates | 1 | 2020 | 4 | 0.160 |
Why?
|
| Sulfoxides | 1 | 2020 | 6 | 0.160 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2020 | 91 | 0.160 |
Why?
|
| Seminal Plasma Proteins | 1 | 2019 | 2 | 0.160 |
Why?
|
| Protein Stability | 2 | 2017 | 106 | 0.160 |
Why?
|
| Molecular Conformation | 2 | 2017 | 111 | 0.160 |
Why?
|
| Global Health | 1 | 2021 | 213 | 0.160 |
Why?
|
| Butyrophilins | 1 | 2020 | 28 | 0.160 |
Why?
|
| Interleukin-23 | 1 | 2020 | 60 | 0.160 |
Why?
|
| Organosilicon Compounds | 1 | 2019 | 8 | 0.160 |
Why?
|
| Carrier Proteins | 1 | 2023 | 684 | 0.160 |
Why?
|
| Complement System Proteins | 1 | 2020 | 86 | 0.160 |
Why?
|
| Candida albicans | 1 | 2019 | 32 | 0.160 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2019 | 31 | 0.150 |
Why?
|
| Lymphocyte Count | 2 | 2021 | 102 | 0.150 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2020 | 120 | 0.150 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2012 | 308 | 0.150 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 66 | 0.150 |
Why?
|
| Rats | 4 | 2023 | 4154 | 0.150 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2019 | 81 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2011 | 325 | 0.150 |
Why?
|
| Virus Diseases | 1 | 2020 | 102 | 0.150 |
Why?
|
| Amyloid | 1 | 2019 | 105 | 0.150 |
Why?
|
| Up-Regulation | 2 | 2019 | 741 | 0.150 |
Why?
|
| Cricetulus | 1 | 2019 | 132 | 0.150 |
Why?
|
| CHO Cells | 1 | 2019 | 196 | 0.150 |
Why?
|
| Antifungal Agents | 1 | 2019 | 126 | 0.150 |
Why?
|
| Serotonergic Neurons | 1 | 2018 | 5 | 0.150 |
Why?
|
| Vaccines, DNA | 1 | 2018 | 19 | 0.140 |
Why?
|
| Relaxin | 1 | 2018 | 9 | 0.140 |
Why?
|
| Biotechnology | 1 | 2018 | 31 | 0.140 |
Why?
|
| Circular Dichroism | 3 | 2016 | 118 | 0.140 |
Why?
|
| Leukocyte Common Antigens | 2 | 2016 | 51 | 0.140 |
Why?
|
| Proteomics | 1 | 2020 | 269 | 0.140 |
Why?
|
| Immunoglobulin A | 3 | 2024 | 91 | 0.140 |
Why?
|
| Receptors, Chemokine | 1 | 2018 | 32 | 0.140 |
Why?
|
| Raphe Nuclei | 1 | 2018 | 38 | 0.140 |
Why?
|
| Protein Structure, Secondary | 3 | 2017 | 342 | 0.140 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2015 | 74 | 0.140 |
Why?
|
| Bronchi | 1 | 2019 | 234 | 0.140 |
Why?
|
| Immunoglobulins | 1 | 2018 | 144 | 0.140 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 114 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2020 | 1157 | 0.140 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2017 | 4 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 359 | 0.140 |
Why?
|
| Single-Chain Antibodies | 1 | 2017 | 21 | 0.140 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2017 | 24 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2023 | 113 | 0.130 |
Why?
|
| Nanostructures | 1 | 2018 | 89 | 0.130 |
Why?
|
| Binding Sites, Antibody | 1 | 2017 | 50 | 0.130 |
Why?
|
| Prevalence | 1 | 2021 | 1349 | 0.130 |
Why?
|
| Antifreeze Proteins | 1 | 2017 | 6 | 0.130 |
Why?
|
| Arthropod Proteins | 1 | 2017 | 8 | 0.130 |
Why?
|
| Fluorenes | 1 | 2017 | 6 | 0.130 |
Why?
|
| Depsipeptides | 1 | 2017 | 32 | 0.130 |
Why?
|
| Pandemics | 5 | 2021 | 880 | 0.130 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2017 | 66 | 0.130 |
Why?
|
| Virus Latency | 1 | 2017 | 35 | 0.130 |
Why?
|
| Immune Tolerance | 1 | 2019 | 385 | 0.130 |
Why?
|
| HIV | 1 | 2017 | 49 | 0.130 |
Why?
|
| Glycine | 1 | 2017 | 96 | 0.130 |
Why?
|
| Vaccinia virus | 1 | 2016 | 20 | 0.130 |
Why?
|
| NAV1.4 Voltage-Gated Sodium Channel | 1 | 2016 | 3 | 0.130 |
Why?
|
| Scorpions | 1 | 2016 | 6 | 0.130 |
Why?
|
| Immunologic Techniques | 1 | 2016 | 27 | 0.130 |
Why?
|
| Immune Sera | 1 | 2016 | 53 | 0.120 |
Why?
|
| Molecular Docking Simulation | 1 | 2016 | 58 | 0.120 |
Why?
|
| Immobilized Proteins | 1 | 2016 | 15 | 0.120 |
Why?
|
| Cross Protection | 1 | 2016 | 11 | 0.120 |
Why?
|
| Caveolin 1 | 1 | 2016 | 25 | 0.120 |
Why?
|
| Virus Shedding | 1 | 2016 | 29 | 0.120 |
Why?
|
| Stem Cells | 1 | 2019 | 394 | 0.120 |
Why?
|
| Adenine | 1 | 2016 | 92 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 2794 | 0.120 |
Why?
|
| Cattle | 1 | 2016 | 387 | 0.120 |
Why?
|
| Microspheres | 1 | 2016 | 105 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 2019 | 513 | 0.120 |
Why?
|
| Anxiety | 1 | 2018 | 339 | 0.120 |
Why?
|
| RNA, Viral | 3 | 2023 | 311 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2016 | 88 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 515 | 0.120 |
Why?
|
| Macrophages | 2 | 2019 | 626 | 0.120 |
Why?
|
| Cell Survival | 1 | 2017 | 1032 | 0.110 |
Why?
|
| Hydrogen Bonding | 2 | 2017 | 154 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 436 | 0.110 |
Why?
|
| Seminiferous Tubules | 1 | 2015 | 9 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 320 | 0.110 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 4 | 0.110 |
Why?
|
| Receptors, CCR6 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Vaccines, Subunit | 1 | 2015 | 55 | 0.110 |
Why?
|
| Enzymes | 1 | 2015 | 47 | 0.110 |
Why?
|
| Lymphocyte Subsets | 1 | 2014 | 69 | 0.110 |
Why?
|
| Catalysis | 1 | 2015 | 216 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1981 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1958 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 606 | 0.110 |
Why?
|
| Adolescent | 4 | 2023 | 9896 | 0.110 |
Why?
|
| Anti-HIV Agents | 1 | 2017 | 199 | 0.110 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 104 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 825 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2018 | 1158 | 0.100 |
Why?
|
| Epoetin Alfa | 1 | 2013 | 2 | 0.100 |
Why?
|
| Isoelectric Focusing | 1 | 2013 | 29 | 0.100 |
Why?
|
| Carbohydrate Sequence | 1 | 2013 | 21 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 432 | 0.100 |
Why?
|
| Forecasting | 1 | 2015 | 317 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 209 | 0.100 |
Why?
|
| Polysaccharides | 1 | 2013 | 96 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2015 | 208 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2015 | 706 | 0.090 |
Why?
|
| Action Potentials | 1 | 2016 | 618 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 108 | 0.090 |
Why?
|
| Cricetinae | 2 | 2023 | 544 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2015 | 922 | 0.090 |
Why?
|
| Surface Plasmon Resonance | 3 | 2017 | 48 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2012 | 368 | 0.090 |
Why?
|
| Models, Biological | 1 | 2018 | 1815 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2014 | 983 | 0.090 |
Why?
|
| Dimerization | 1 | 2011 | 150 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 483 | 0.080 |
Why?
|
| Models, Chemical | 1 | 2011 | 187 | 0.080 |
Why?
|
| Time Factors | 2 | 2017 | 5585 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 336 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 7232 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2023 | 9173 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2015 | 541 | 0.080 |
Why?
|
| Escherichia coli | 3 | 2019 | 627 | 0.080 |
Why?
|
| Biomarkers | 3 | 2025 | 1933 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 2422 | 0.080 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2011 | 329 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2059 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 3490 | 0.080 |
Why?
|
| Immunophenotyping | 2 | 2020 | 226 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 212 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2020 | 102 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2021 | 727 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2020 | 482 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 3250 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2025 | 49 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2024 | 140 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2024 | 72 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2025 | 479 | 0.050 |
Why?
|
| Extinction, Psychological | 1 | 2023 | 21 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 220 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2017 | 10286 | 0.050 |
Why?
|
| Ferritins | 1 | 2023 | 31 | 0.050 |
Why?
|
| Fear | 1 | 2023 | 87 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2023 | 126 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2022 | 112 | 0.050 |
Why?
|
| Virion | 1 | 2022 | 62 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2023 | 159 | 0.050 |
Why?
|
| Mass Vaccination | 1 | 2021 | 10 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 20 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 77 | 0.040 |
Why?
|
| Camelids, New World | 1 | 2021 | 4 | 0.040 |
Why?
|
| Oxazines | 1 | 2021 | 15 | 0.040 |
Why?
|
| Oxazoles | 1 | 2021 | 18 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2021 | 37 | 0.040 |
Why?
|
| Convalescence | 1 | 2021 | 13 | 0.040 |
Why?
|
| Metal Nanoparticles | 1 | 2021 | 34 | 0.040 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2021 | 19 | 0.040 |
Why?
|
| Receptors, CXCR3 | 1 | 2021 | 13 | 0.040 |
Why?
|
| Gold | 1 | 2021 | 44 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2021 | 29 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2021 | 123 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 872 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 65 | 0.040 |
Why?
|
| Peptide Library | 1 | 2021 | 85 | 0.040 |
Why?
|
| Polyproteins | 1 | 2020 | 4 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 111 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 165 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2021 | 115 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 47 | 0.040 |
Why?
|
| Eye | 1 | 2021 | 112 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 106 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2020 | 85 | 0.040 |
Why?
|
| Halogenation | 1 | 2020 | 8 | 0.040 |
Why?
|
| Fluorine | 1 | 2020 | 17 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 668 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2021 | 171 | 0.040 |
Why?
|
| Microvessels | 1 | 2020 | 74 | 0.040 |
Why?
|
| Safety | 1 | 2020 | 147 | 0.040 |
Why?
|
| Rabbits | 1 | 2021 | 639 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 263 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2021 | 276 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2021 | 281 | 0.040 |
Why?
|
| Respiratory Burst | 1 | 2019 | 19 | 0.040 |
Why?
|
| Child | 2 | 2021 | 7626 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2019 | 23 | 0.040 |
Why?
|
| Candidiasis | 1 | 2019 | 39 | 0.040 |
Why?
|
| Viral Core Proteins | 1 | 2019 | 28 | 0.040 |
Why?
|
| Solubility | 1 | 2020 | 190 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 165 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2019 | 53 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2019 | 64 | 0.040 |
Why?
|
| Haplorhini | 1 | 2019 | 81 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 1010 | 0.040 |
Why?
|
| Injections, Intradermal | 1 | 2018 | 19 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 124 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 66 | 0.040 |
Why?
|
| Swine Diseases | 1 | 2018 | 15 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 1874 | 0.040 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2018 | 2 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 1267 | 0.040 |
Why?
|
| Electroporation | 1 | 2018 | 57 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2020 | 564 | 0.040 |
Why?
|
| Antibody-Producing Cells | 1 | 2018 | 17 | 0.040 |
Why?
|
| Water | 1 | 2020 | 307 | 0.030 |
Why?
|
| Dogs | 1 | 2019 | 719 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2018 | 101 | 0.030 |
Why?
|
| Protein Transport | 1 | 2019 | 439 | 0.030 |
Why?
|
| Prosencephalon | 1 | 2018 | 68 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 1645 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 246 | 0.030 |
Why?
|
| HIV Long-Term Survivors | 1 | 2017 | 2 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 173 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 309 | 0.030 |
Why?
|
| Caffeine | 1 | 2018 | 86 | 0.030 |
Why?
|
| DNA Primers | 1 | 2018 | 548 | 0.030 |
Why?
|
| Proof of Concept Study | 1 | 2017 | 57 | 0.030 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2020 | 186 | 0.030 |
Why?
|
| Siphonaptera | 1 | 2017 | 8 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2021 | 464 | 0.030 |
Why?
|
| Genome | 1 | 2020 | 407 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2022 | 2163 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 618 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 91 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2016 | 20 | 0.030 |
Why?
|
| Perforin | 1 | 2016 | 56 | 0.030 |
Why?
|
| Base Sequence | 1 | 2020 | 2344 | 0.030 |
Why?
|
| Granzymes | 1 | 2016 | 96 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2020 | 781 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 132 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 422 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 2016 | 89 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 360 | 0.030 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2016 | 42 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2017 | 329 | 0.030 |
Why?
|
| Calibration | 1 | 2016 | 108 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 938 | 0.030 |
Why?
|
| Virus Replication | 1 | 2017 | 326 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 3240 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 150 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 891 | 0.030 |
Why?
|
| Thermus | 1 | 2015 | 5 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 1275 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 286 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 943 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 122 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2017 | 503 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2014 | 128 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3974 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2012 | 18 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 1322 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1192 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2012 | 124 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2883 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1653 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2016 | 763 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 5960 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 4374 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2482 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3651 | 0.020 |
Why?
|